Topic Hub
85 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 85 of 85 clinical reviews.
A clinical head-to-head comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) for erectile dysfunction across special populations including post-prostatectomy, diabetes, cardiovascular disease, and spinal cord injury. Evidence-based guidance on switching and selection.
Read clinical reviewA physician-reviewed comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) for erectile dysfunction, including when and how clinicians combine both agents, dosing, safety data, and who should switch or add therapy.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) for erectile dysfunction, covering efficacy, safety, dosing, and when to switch, backed by real-world trial data.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) for erectile dysfunction, drawing on randomized trials, real-world evidence, and prescribing guidelines to help you and your clinician choose.
Read clinical reviewA clinician-reviewed comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) across special populations including diabetes, post-prostatectomy, cardiovascular disease, older adults, and renal/hepatic impairment. Backed by trial data and real-world evidence.
Read clinical reviewA detailed clinical comparison of tadalafil (Cialis) versus alprostadil (Caverject/MUSE) for erectile dysfunction, covering long-term durability of response, trial data, switching protocols, and when each option fits.
Read clinical reviewA detailed clinical comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) covering titration protocols, tolerability profiles, efficacy data, and how to decide which agent fits your situation.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and alprostadil (Caverject/MUSE) for erectile dysfunction, including what to do when one stops working or never worked at all.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) versus generic sildenafil, including the pharmacology behind combining them, the real risks of dual PDE5 inhibitor use, and how to choose between the two.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and generic sildenafil for long-term erectile function durability, covering trial data, dosing strategies, switching protocols, and real-world outcomes.
Read clinical reviewA deep clinical comparison of tadalafil (Cialis) vs generic sildenafil for erectile dysfunction, drawing on head-to-head trials, pharmacokinetics, safety data, and real-world evidence to help you and your doctor choose the right option.
Read clinical reviewA rigorous clinical comparison of tadalafil (Cialis) versus generic sildenafil across special populations including men with diabetes, cardiovascular disease, BPH, spinal cord injury, and after radical prostatectomy. Backed by named trials, real doses, and guideline references.
Read clinical reviewA clinical head-to-head comparison of tadalafil (Cialis) vs generic sildenafil on titration speed, side-effect profile, and real-world tolerability, reviewed by the HealthRX medical team.
Read clinical reviewTadalafil (Cialis) and generic sildenafil work differently enough that failure on one does not predict failure on the other. Learn the clinical evidence, switching protocols, and dosing strategies that give men the best chance at response.
Read clinical reviewCialis and generic tadalafil contain the same active molecule. Learn why combining them is never appropriate, how to switch safely, and what the clinical evidence says about tadalafil dosing for erectile dysfunction.
Read clinical reviewA clinical comparison of brand Cialis and generic tadalafil covering titration schedules, side-effect profiles, dosing flexibility, and how to switch safely between formulations.
Read clinical reviewBrand Cialis and generic tadalafil contain the same molecule, yet some men respond differently. Learn why, what the evidence says, and exactly what steps to take when either one stops working.
Read clinical reviewA clinical comparison of brand Cialis and generic tadalafil for long-term erectile function, including trial data, dosing, bioequivalence evidence, and guidance on switching.
Read clinical reviewA thorough, citation-dense comparison of brand Cialis and generic tadalafil covering pharmacokinetics, clinical trial data, real-world effectiveness, cost, and switching guidance for men with ED or BPH.
Read clinical reviewA clinical deep-dive comparing brand Cialis to generic tadalafil in special populations including men with diabetes, cardiovascular disease, BPH, renal impairment, and older adults. Dosing, safety, and switching guidance from named trials and guidelines.
Read clinical reviewA thorough clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn), covering mechanism differences, head-to-head trial data, switching rationale, and the serious risks of combining both PDE5 inhibitors.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) for long-term erectile function, covering trial data, durability benchmarks, switching criteria, and dosing guidance reviewed by the HealthRX medical team.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) covering titration speed, side-effect profiles, dosing schedules, and which drug may suit which patient.
Read clinical reviewA clinician-reviewed comparison of tadalafil (Cialis) and vardenafil (Levitra/Staxyn) for erectile dysfunction, including what the evidence says about switching when one drug stops working.
Read clinical reviewA physician-reviewed comparison of tadalafil (Cialis) and sildenafil (Viagra) in special populations including men with diabetes, cardiovascular disease, post-prostatectomy, BPH, and older age. Includes trial data, dosing guidance, and switching criteria.
Read clinical reviewA clinician-reviewed comparison of tadalafil (Cialis) and sildenafil (Viagra), covering why some men consider using both, the pharmacological rationale, and the real safety risks of combining two PDE5 inhibitors.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and sildenafil (Viagra) for long-term erectile function durability, covering trial data, dosing schedules, safety, and when to switch.
Read clinical reviewA head-to-head comparison of tadalafil (Cialis) and sildenafil (Viagra) drawing on landmark clinical trials, real-world outcomes data, and current prescribing guidelines to help patients and clinicians choose the right PDE5 inhibitor.
Read clinical reviewA head-to-head clinical comparison of tadalafil (Cialis) and sildenafil (Viagra) covering dose titration schedules, tolerability profiles, onset times, and how to decide which PDE5 inhibitor fits your lifestyle.
Read clinical reviewTadalafil didn't work? Sildenafil underwhelming? This evidence-based guide walks through why PDE5 inhibitors fail, how to optimize the one you're on, and exactly when switching makes clinical sense.
Read clinical reviewA clinical comparison of sildenafil and alprostadil for erectile dysfunction, including when to combine them, what the evidence shows, and how to manage combination risks.
Read clinical reviewA head-to-head clinical comparison of sildenafil generic and alprostadil (Caverject/MUSE) for erectile dysfunction, covering long-term durability, dropout rates, efficacy data, and when to switch, reviewed by the HealthRX medical team.
Read clinical reviewA head-to-head comparison of generic sildenafil and alprostadil (Caverject/MUSE) for erectile dysfunction, covering efficacy, safety, tolerability, and when to switch, based on clinical trials and real-world evidence.
Read clinical reviewA clinical comparison of sildenafil (generic) and alprostadil (Caverject/MUSE) for erectile dysfunction in special populations, including men with diabetes, spinal cord injury, post-prostatectomy, and cardiovascular disease. Covers efficacy, safety, dosing, and when to switch.
Read clinical reviewA detailed clinical comparison of sildenafil generic tablets vs alprostadil injection (Caverject) and suppository (MUSE) for erectile dysfunction, covering titration protocols, side-effect profiles, and which patients do better on each drug.
Read clinical reviewA clinical comparison of generic sildenafil and generic tadalafil for erectile dysfunction, including pharmacology, head-to-head trial data, patient-selection criteria, and the evidence for and against combining both PDE5 inhibitors.
Read clinical reviewA head-to-head clinical comparison of generic sildenafil and generic tadalafil for erectile dysfunction, covering long-term efficacy, durability of response, switching criteria, and dosing strategies backed by trial data.
Read clinical reviewA clinical comparison of generic sildenafil and generic tadalafil for erectile dysfunction, covering mechanism, onset, duration, dosing, side effects, and real-world outcomes from named trials and registry data.
Read clinical reviewA clinical comparison of generic sildenafil and generic tadalafil across special populations including men with diabetes, post-prostatectomy, cardiovascular disease, BPH, and older adults. Evidence-based dosing, safety, and switching guidance.
Read clinical reviewA head-to-head clinical comparison of generic sildenafil and generic tadalafil covering dose titration schedules, side-effect profiles, onset timing, and practical switching guidance for men with erectile dysfunction.
Read clinical reviewA clinician-reviewed guide comparing sildenafil and tadalafil for erectile dysfunction, with a step-by-step protocol for switching when one PDE5 inhibitor stops working or never worked.
Read clinical reviewA clinical comparison of sildenafil and vardenafil for erectile dysfunction, including onset, duration, dosing, side-effect profiles, and why combining both PDE5 inhibitors is contraindicated.
Read clinical reviewA clinical comparison of sildenafil generic vs vardenafil (Levitra/Staxyn) for long-term erectile function: trial data, durability evidence, real-world switching, and dosing guidance.
Read clinical reviewA clinician-reviewed, evidence-based comparison of sildenafil (generic) vs vardenafil (Levitra/Staxyn) for erectile dysfunction, covering efficacy, side effects, dosing, food interactions, and when to switch.
Read clinical reviewA clinical comparison of sildenafil and vardenafil for erectile dysfunction in special populations including diabetes, cardiovascular disease, older adults, and post-prostatectomy patients. Backed by trial data and physician guidance.
Read clinical reviewA detailed clinical comparison of sildenafil generic vs vardenafil (Levitra/Staxyn) covering titration protocols, onset speed, side-effect profiles, and which patients do better on each drug.
Read clinical reviewA clinician-reviewed comparison of sildenafil and vardenafil for erectile dysfunction, including dosing, mechanism differences, and a step-by-step switching protocol when one PDE5 inhibitor stops working.
Read clinical reviewA clinical head-to-head comparison of tadalafil (generic) and alprostadil (Caverject/MUSE) for erectile dysfunction in special populations, including men with diabetes, post-prostatectomy, cardiovascular disease, and PDE5 inhibitor failure.
Read clinical reviewA clinical comparison of tadalafil (generic) and alprostadil (Caverject/MUSE) for erectile dysfunction, including the pharmacological rationale and risk profile for combining both agents.
Read clinical reviewA clinical comparison of tadalafil (generic) and alprostadil (Caverject/MUSE) for erectile dysfunction, covering long-term durability of response, trial data, real-world adherence, and guidance on switching therapies.
Read clinical reviewA clinician-reviewed, evidence-based comparison of generic tadalafil and alprostadil (Caverject/MUSE) for erectile dysfunction, covering efficacy, safety, tolerability, and when to switch.
Read clinical reviewA head-to-head clinical comparison of generic tadalafil versus alprostadil (Caverject injection and MUSE suppository) covering titration protocols, side-effect profiles, onset times, and which patients are best suited to each therapy.
Read clinical reviewA clinician-reviewed comparison of tadalafil (generic) and alprostadil (Caverject/MUSE) for erectile dysfunction, including what to do when one stops working, how to switch, and when combination therapy is appropriate.
Read clinical reviewA detailed clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) across special populations including diabetes, cardiovascular disease, post-prostatectomy, elderly men, and renal/hepatic impairment. Evidence-based guidance for choosing or switching between these two PDE5 inhibitors.
Read clinical reviewA clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) for erectile dysfunction, including the evidence on whether combining the two is ever justified and what the real risks are.
Read clinical reviewA clinical comparison of tadalafil generic vs vardenafil (Levitra/Staxyn) for long-term erectile durability, covering trial data, real-world persistence, dose escalation, and when to switch.
Read clinical reviewA direct clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) using head-to-head trial data, real-world outcomes, dosing windows, side-effect profiles, and patient-preference research to help you and your prescriber choose.
Read clinical reviewA clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) covering dose titration schedules, onset windows, side-effect profiles, and guidance on switching between the two PDE5 inhibitors.
Read clinical reviewA clinical comparison of tadalafil generic and vardenafil (Levitra/Staxyn) for erectile dysfunction, including what evidence says about switching when one PDE5 inhibitor stops working.
Read clinical reviewA clinical head-to-head comparing vardenafil and alprostadil for erectile dysfunction in special populations including diabetes, post-prostatectomy, cardiovascular disease, and spinal cord injury. Real trial data, named guidelines, and dosing specifics.
Read clinical reviewShowing the first 60 matches. Use search or filters to narrow the library.